Efficacy and Safety of Ruxolitinib Cream by Anatomic Region in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From TRuE-AD3. (2024). SKIN The Journal of Cutaneous Medicine, 8(6), s453. https://doi.org/10.25251/skin.8.supp.453